CompletedNCT00493233
Two antipsychotics together or one antipsychotic for schizophrenia
About this title
Read the official source — NCT00493233Medication studyAges 18–80Canada
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 80 years. Other eligibility criteria applied.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateNovember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Canada
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT00493233
- Official title
Show the full official title
Antipsychotic Polypharmacy in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including main antipsychotic medication and placebo.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 80 years. Other eligibility criteria applied.
